EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A multispecies toolkit of TOP2 hypercleavage mutants for studying topoisomerase II–mediated DNA damage

David Ontoso, Monika Mehta, Aidin Shabro, John Dittmar, Robert J D Reid, Rodney Rothstein, John L Nitiss, Scott Keeney iD

Proceedings of the National Academy of Sciences · 2026

DOI: 10.1073/pnas.2616452123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2026. Verfasst von David Ontoso und 7 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065. Hauptthemen laut MEDLINE: DNA Topoisomerases, Type II, Saccharomyces cerevisiae Proteins, Poly-ADP-Ribose Binding Proteins, DNA Damage. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HHS | NIH | National Institute of General Medical Sciences (NIGMS), NIGMS NIH HHS, MSK Center for Metastasis Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

DNA topoisomerase II (TOP2) generates transient DNA double-strand breaks that are trapped as TOP2-DNA covalent complexes (TOP2cc) by antibiotic and chemotherapy drugs. Here, we characterize tools for study of cellular responses to TOP2cc, exploiting a Saccharomyces cerevisiae TOP2 mutant ( TOP2-F1025Y,R1128G ) that generates spontaneous and inhibitor-induced covalent complexes at elevated frequencies. This Top2-hc (for “hypercleavage”) mutant protein inhibits yeast cell growth when expressed alone or with endogenous Top2, and growth defects are exacerbated in DNA-repair-deficient genetic backgrounds and/or in the presence of low doses of the Top2 poison mAMSA. We generated analogous mutations in human and mouse TOP2A and TOP2B that gave increased TOP2cc, hypersensitization to topoisomerase poisons, increased DNA damage, and decreased cell survival in cultured cells. We further established knock-in mouse models with inducible, tissue-specific expression of each TOP2-hc isoform, demonstrating overt organismal toxicity and cellular markers of DNA damage responses. To illustrate the potential of these genetic tools, we carried out proof-of-principle screens in yeast and cultured human cells for sensitivity to TOP2-hc. The yeast screen revealed strong requirements for homologous recombination, moderate roles for sister chromatid cohesion and kinetochore function, and dependencies on vesicle and vacuolar functions. The pilot shRNA screen in human cells revealed shared requirements for resistance to expression of either TOP2A-hc or TOP2B-hc as well as examples of isoform specificity. These findings establish hypercleavage mutant proteins as effective tools for studying topoisomerase isoform-specific DNA damage and offer a foundation for exploring TOP2cc toxicity and tolerance in vivo.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA Topoisomerases, Type IISaccharomyces cerevisiae ProteinsPoly-ADP-Ribose Binding ProteinsDNA DamageSaccharomyces cerevisiaeAnimalsHumansMiceTopoisomerase II InhibitorsMutationDNA Breaks, Double-StrandedDNA RepairAntigens, Neoplasm

Stichwörter der Autor:innen

DNA double-strand breakSaccharomyces cerevisiaeTopoisomerase II

Substanzen

DNA Topoisomerases, Type IISaccharomyces cerevisiae ProteinsPoly-ADP-Ribose Binding ProteinsTOP2A protein, humanTopoisomerase II InhibitorsTop2a protein, mouseTOP2 protein, S cerevisiaeTop2b protein, mouseTOP2B protein, humanAntigens, Neoplasm

Autor:innen und Institutionen

  • Molecular Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065.
  • HHMI, Memorial Sloan Kettering Cancer Center, New York, NY 10065.
  • Department of Biological Sciences, Columbia University, New York, NY 10027.
  • Department of Genetics and Development (in Systems Biology), Columbia University Irving Medical Center, New York, NY 10032.
  • Pharmaceutical Sciences Department, Retzky College of Pharmacy, University of Illinois Chicago, Rockford, IL 61107.

ORCID-Profile: Scott Keeney

Förderung

  • HHS | NIH | National Institute of General Medical Sciences (NIGMS)
  • NIGMS NIH HHS
  • MSK Center for Metastasis Research
  • HHS | NIH | National Cancer Institute (NCI)
  • NCI NIH HHS
  • Starr Cancer Consortium (SCC)

Zitieren

APA

Ontoso, D., Mehta, M., Shabro, A., Dittmar, J., Reid, R. J. D., Rothstein, R., Nitiss, J. L., & Keeney, S. (2026). A multispecies toolkit of TOP2 hypercleavage mutants for studying topoisomerase II–mediated DNA damage. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2616452123

Vancouver

Ontoso D, Mehta M, Shabro A, Dittmar J, Reid RJD, Rothstein R, et al. A multispecies toolkit of TOP2 hypercleavage mutants for studying topoisomerase II–mediated DNA damage. Proceedings of the National Academy of Sciences. 2026. doi:10.1073/pnas.2616452123

BibTeX
@article{Ontoso2026,
  author = {Ontoso, David and Mehta, Monika and Shabro, Aidin and Dittmar, John and Reid, Robert J D and Rothstein, Rodney and Nitiss, John L and Keeney, Scott},
  title = {A multispecies toolkit of TOP2 hypercleavage mutants for studying topoisomerase II–mediated DNA damage},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2026},
  doi = {10.1073/pnas.2616452123}
}
Kostenlos starten →